title: Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer.
authors.forename: A W
authors.initials: AW
authors.lastname: Menzin
authors.forename: S A
authors.initials: SA
authors.lastname: King
authors.forename: J K
authors.initials: JK
authors.lastname: Aikins
authors.forename: J J
authors.initials: JJ
authors.lastname: Mikuta
authors.forename: S C
authors.initials: SC
authors.lastname: Rubin
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary; D000368:Aged; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*; D016879:Salvage Therapy; D012878:Skin Neoplasms / Q000188:drug therapy / Q000556:secondary*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
chemical_list: D017239:Paclitaxel